Results 161 to 170 of about 3,549 (185)

Pegfilgrastim

Reactions Weekly, 2018
  +4 more sources

Pharmacokinetic and Pharmacodynamic Equivalence of Pegfilgrastim-cbqv and Pegfilgrastim in Healthy Subjects

Advances in Therapy, 2020
Barbara Finck, Francesca Civoli
exaly  

Pharmacokinetic/Pharmacodynamic Modeling of Pegfilgrastim in Healthy Subjects

Journal of Clinical Pharmacology, 2006
Lorin K Roskos, Bing-Bing Yang
exaly  

A demonstration of analytical similarity comparing a proposed biosimilar pegfilgrastim and reference pegfilgrastim

Biologicals, 2017
Nirmesh Shāh
exaly  

Serum Pegfilgrastim Concentrations During Recovery of Absolute Neutrophil Count in Patients with Cancer Receiving Pegfilgrastim After Chemotherapy

Pharmacotherapy, 2007
Bing-Bing Yang
exaly  

Economic modeling for the US of the cost-efficiency and associated expanded treatment access of conversion to biosimilar pegfilgrastim-bmez from reference pegfilgrastim

Journal of Medical Economics, 2020
, Weijia Wang, Kim Campbell
exaly  

Pegfilgrastim

Reactions Weekly, 2007
openaire   +1 more source

Pegfilgrastim

Reactions Weekly, 2021
openaire   +1 more source

Pegfilgrastim

Reactions Weekly, 2014
openaire   +2 more sources

Dose response of pegfilgrastim in Japanese breast cancer patients receiving six cycles of docetaxel, doxorubicin, and cyclophosphamide therapy: a randomized controlled trial

Supportive Care in Cancer, 2015
Norikazu Masuda, Seigo Nakamura, Kazuo Tamura   +2 more
exaly